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Q Do corticosteroid injections 
improve carpal tunnel syndrome 
symptoms? 
EVIDENCE-BASED ANSWER
A Yes. injected corticosteroids   reduce symptoms of carpal tun-
nel syndrome (CTS) more effectively than 
placebo or systemic steroids, but no better 
than anti-inflammatory medication and 
splinting, from one to 12 weeks after ther-
apy (strength of recommendation [SOR]: 
A, meta-analysis of randomized controlled 
trials [RCTs] and consistent RCT).
A 40-mg injection of methylpredniso-
lone reduces symptoms as effectively as an 
80-mg injection for as long as 10 weeks, but 
the 80-mg dose reduces progression to sur-
gery at one year (SOR: B, RCT). Long-term 
effects of injections decrease by 12 months 
(SOR: B, RCT). 
After corticosteroid injections, 14% of 
patients proceed to surgery at one year, and 
33% proceed to surgery at 5 years (SOR: B, 
cohort trial).
Evidence summary
A 2007 Cochrane review of 12 RCTs with 
671 patients compared the efficacy of corti-
costeroid injections for CTS with placebo in-
jections or other nonsurgical interventions.1 
Patients who received corticosteroid injec-
tions showed clinical improvement at one 
month or less compared with placebo (2 tri-
als, 141 patients; 73% corticosteroids vs 28% 
placebo; relative risk [RR]=2.58; 95% confi-
dence interval [CI], 1.72-3.87; number need-
ed to treat [NNT]=2). 
Compared with systemic corticosteroids, 
corticosteroid injections didn’t improve 
symptoms on a Global Symptom Score (scale 
of 0-50, with 50 indicating the most severe 
symptoms) at 2 weeks (one trial, 60 patients; 
mean difference [MD]= −4.2; 95% CI, −8.7 to 
0.26), but did improve symptoms at 8 weeks 
(MD= −7.16; 95% CI, −11.5 to −2.86) and 
12 weeks (MD= −7.1; 95% CI, −11.7 to −2.52). 
Patients showed no difference in scores 
between corticosteroid injection and oral 
anti-inflammatory medication with neutral 
angle wrist splints on the Symptom Severity 
Scale (1 to 5, with 5 indicating the most se-
vere symptoms) at 2 weeks (1 trial, 23 patients 
[37 wrists]; MD=0.0; 95% CI, −0.64 to 0.64) or 
8 weeks (MD=0.1; 95% CI, −0.33 to 0.53). 
Higher corticosteroid dose  
reduces surgery at one year
A 2013 high-quality RCT with 111 patients as-
sessed pain relief and rates of surgery at one 
year with local corticosteroid injections for 
CTS.2 This trial had 3 arms with 37 patients in 
each: 80-mg methylprednisolone injection, 
40-mg methylprednisolone injection, or pla-
cebo injection. 
Both corticosteroid groups showed 
greater improvement on the Symptom Sever-
ity Scale at 10 weeks compared with placebo 
(40-mg methylprednisolone group: MD= 
−0.88; 95% CI, −1.3 to −0.46; 80-mg meth-
ylprednisolone group: MD= −0.64; 95% CI, 
−1.06 to −0.21). There was no difference be-
tween the methylprednisolone groups. 
The incidence of surgery at one year 
was lower in the 80-mg methylpredniso-
lone group compared with placebo (73% vs 
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92%; RR=0.79; 95% CI, 0.64-0.99; NNT=5) 
but not in the 40-mg methylprednisolone 
group compared with placebo (81% vs 92%; 
RR=0.88; 95% CI, 0.73-1.06).
Corticosteroids improve symptoms  
and disability, but effects wear off
A randomized double-blind, placebo- 
controlled trial conducted in 2010 examined 
the effectiveness of corticosteroid injections 
given by general practitioners to 69 patients 
with CTS.3 Patients were randomized to re-
ceive 10 mg of either triamcinolone or sa-
line. They were reassessed after one week, 
and patients in the saline injection group 
who had inadequate symptom relief re-
ceived a triamcinolone injection as bail-out 
treatment. Follow-up by patient question-
naire was done at 1, 3, 6, and 12 months. 
Investigators assessed symptoms and 
disability using the Symptom Severity Scale 
and Functional Disability Scale, which are 
part of the Boston Carpal Tunnel Question-
naire. Like the Symptom Severity Scale, the 
Functional Disability Scale is scored from 1 to 
5, with higher scores indicating more severe 
disability. 
One week after treatment, the cortico-
steroid group showed greater improvement 
in symptom severity and functional disability 
than the saline group (symptom severity de-
creased from 2.9 to 1.9 with triamcinolone vs 
2.8 to 2.5 with saline; MD=0.64; 95% CI, 0.32-
0.96; functional disability decreased from 
2.5 to 1.9 with triamcinolone but remained at 
2.4 with saline; MD=0.59; 95% CI, 0.23-0.94).  
Long-term follow-up of 35 patients who 
responded to corticosteroid injections found 
that the effects wore off over 12 months when 
assessed using the Symptom Severity Scale 
(mean score 1.5 at 1 month, 2.0 at 12 months; 
P=.08).
Surgery rates at one and 5 years
A 2012 prospective cohort study examined 
the 5-year rate of surgical intervention after 
a 20-mg methylprednisolone injection in 
824 patients diagnosed with CTS who had 
failed conservative treatment.4 A total of 
500 patients had a relapse of symptoms, and 
372 of them elected to have a second injec-
tion. A Kaplan-Meier survivorship analysis 
determined rates of surgical intervention to 
be 14.5% (95% CI, 11.9-17) at one year and 
33.2% (95% CI, 28.7-37.8) at 5 years.
Recommendation 
A 2010 American Academy of Orthopaedic 
Surgeons evidence-based practice guide-
line on the treatment of CTS  recommends 
corticosteroid injection before considering 
surgery (Grade B, Level 1 suggested recom-
mendation with good evidence).5                          JFP
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